World News

Assisted Reproduction Technology Devices Market 2024 Industry Trends, Growth, Analysis, Opportunities and Overview

Press Release

The number of infertile women across the globe has grown considerably in the last one or two decades. According to various national health surveys, the number of women facing secondary infertility was 10.5% in 2010 and since then the figure is increasing. Stats also reveal that nearly 50 million couples across the globe experience infertility. Fallopian tube damage or blockage is considered as one of the key factors behind infertility. Other reasons include ovulation disorders, endometriosis, uterine or cervical abnormalities, primary ovarian insufficiency (early menopause), and cancer and its treatment. Apart from these, some crucial factors are increasing smoking habits, high consumption of alcohol, and obesity.

Report Overview @

To counter increasing infertility and to release taboo linked with it; assistive reproductive technology is one such way. In vitro fertilization, surrogacy, and artificial insemination are some of the most preferred assisted reproductive technology used by the people experiencing infertility. Among these, in virto fertilization technology is popular among people as they aware of it and its benefits. Standardization through regulatory reforms, automation, and government funding to store egg-sperm are the main factors rising demand for in virto fertilization.

Request Brochure @

Moreover, government funding is also used for experiments that will later benefit in reducing cost and increase the success rate of these technologies. For example, in Canada, the Toronto Centre for Advanced Reproductive Technology (TCART) offered free in virto fertilization to at least 60 women to experiment with the AUGMENT rejuvenating technique. It was the first Canadian Clinic to take such an initiative. In this technique, older cells are allowed to rejuvenate by collecting smaller cells from the external layer of the ovary. Thus, this technique helped to harvest of young cells and resulted in providing higher treatment success rates.

This post was originally published on Industry Updates Daily